BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34971477)

  • 21. Association Study of MECP2 Gene Single Nucleotide Polymorphisms in Juvenile-Onset Systemic Lupus Erythematosus Patients from Iran.
    Mahmoudi M; Aslani S; Hamzeh E; Ziaee V; Poursani S; Nicknam MH; Rezaei N
    Fetal Pediatr Pathol; 2017 Dec; 36(6):423-431. PubMed ID: 29199882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inadequate dietary intake of children and adolescents with juvenile idiopathic arthritis and systemic lupus erythematosus.
    Caetano MC; Ortiz TT; Terreri MT; Sarni RO; Silva SG; Souza FI; Hilário MO
    J Pediatr (Rio J); 2009; 85(6):509-15. PubMed ID: 19865782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus.
    Mahmoudi M; Tahghighi F; Ziaee V; Harsini S; Rezaei A; Soltani S; Sadr M; Moradinejad MH; Aghighi Y; Rezaei N
    Int J Immunogenet; 2014 Dec; 41(6):512-7. PubMed ID: 25320043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variants in TNFAIP3, STAT4, and C12orf30 loci associated with multiple autoimmune diseases are also associated with juvenile idiopathic arthritis.
    Prahalad S; Hansen S; Whiting A; Guthery SL; Clifford B; McNally B; Zeft AS; Bohnsack JF; Jorde LB
    Arthritis Rheum; 2009 Jul; 60(7):2124-30. PubMed ID: 19565500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrum of paediatric rheumatic diseases in Nigeria.
    Olaosebikan BH; Adelowo OO; Animashaun BA; Akintayo RO
    Pediatr Rheumatol Online J; 2017 Jan; 15(1):7. PubMed ID: 28143550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts.
    Nordang GB; Viken MK; Amundsen SS; Sanchez ES; Flatø B; Førre OT; Martin J; Kvien TK; Lie BA
    Rheumatology (Oxford); 2012 Apr; 51(4):619-26. PubMed ID: 22179739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus.
    Rianthavorn P; Chokedeemeeboon C; Deekajorndech T; Suphapeetiporn K
    Lupus; 2013 Jun; 22(7):721-6. PubMed ID: 23640982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of
    Zhang TP; Li R; Huang Q; Pan HF; Ye DQ; Li XM
    J Immunol Res; 2020; 2020():8528976. PubMed ID: 33145364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum protein signatures differentiate paediatric autoimmune/inflammatory disorders.
    Carlsson E; Midgley A; Perkins S; Caamano-Gutierrez E; Gritzfeld JF; Beresford MW; Hedrich CM
    Clin Immunol; 2021 Aug; 229():108790. PubMed ID: 34197952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.
    Furia FF; Godfrey E; Mwamanenge N; Swai P
    Pediatr Rheumatol Online J; 2020 Apr; 18(1):30. PubMed ID: 32245494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic predisposition between coronavirus disease 2019 and rheumatic diseases: A 2-sample Mendelian randomization study.
    Quan L; Tan J; Hua L; You X
    Int J Rheum Dis; 2023 Apr; 26(4):710-717. PubMed ID: 36890668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort.
    Said MA; Silva LSTE; de Oliveira Rocha AM; Alves GGB; Piotto DGP; Len CA; Terreri MT
    Adv Rheumatol; 2020 Nov; 60(1):53. PubMed ID: 33153496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A home-based exercise program during COVID-19 pandemic: Perceptions and acceptability of juvenile systemic lupus erythematosus and juvenile idiopathic arthritis adolescents.
    Sieczkowska SM; Astley C; Marques IG; Iraha AY; Franco TC; Ihara BP; Martins Lavorato SS; Lindoso L; Demitrol Setoue DN; Tanigava NY; Campos LMA; Pereira RMR; Aikawa NE; Roschel H; Queiroz LB; Polanczyk GV; Silva CA; Gualano B
    Lupus; 2022 Apr; 31(4):443-456. PubMed ID: 35264025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AGER gene variant as a risk factor for juvenile idiopathic arthritis.
    Bakutenko IY; Haurylchyk ID; Sechko EV; Tchitchko AM; Batyan GM; Sukalo AV; Ryabokon NI
    J Gene Med; 2022 Feb; 24(2):e3399. PubMed ID: 34806241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haploinsufficiency of NADPH Oxidase Subunit Neutrophil Cytosolic Factor 2 Is Sufficient to Accelerate Full-Blown Lupus in NZM 2328 Mice.
    Jacob CO; Yu N; Yoo DG; Perez-Zapata LJ; Barbu EA; Kaplan MJ; Purmalek M; Pingel JT; Idol RA; Dinauer MC
    Arthritis Rheumatol; 2017 Aug; 69(8):1647-1660. PubMed ID: 28471497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammasome polymorphisms in juvenile systemic lupus erythematosus.
    Pontillo A; Reis EC; Liphaus BL; Silva CA; Carneiro-Sampaio M
    Autoimmunity; 2015; 48(7):434-7. PubMed ID: 26182076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis.
    Serra CR; Rodrigues SH; Silva NP; Sztajnbok FR; Andrade LE
    Clin Exp Rheumatol; 1999; 17(3):375-80. PubMed ID: 10410276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
    Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
    Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
    Massias JS; Smith EMD; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
    Lupus; 2020 Apr; 29(5):474-481. PubMed ID: 32233733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.